Since April 2020, the number of users of DAA treatment has shown an increasing trend, indicating that the national hepatitis C medical insurance policies have played a role in promoting the promotion and use of DAA treatment.
← all excerpts
Evaluation of the implementation effect of hepatitis C medical insurance reimbursement policy in China: A RWS based on medical institutions.
1
—
—